Glaxo, Astra, Roche back stem cells for drug tests

October 3, 2007

Three of Europe’s top drugmakers have backed a new public-private scheme to use stem cells for safety testing of experimental medicines, signaling “big pharma’s” growing interest in the controversial field. (Scientific American)